The legacy of Viagra and its influence on the pharmaceutical sector presents a complex question regarding its continued appeal as an investment. Initially a blockbuster success, generating huge sums , generic competition has significantly eroded financial returns. While major pharmaceutical firms hold patents on related therapies and investigate ne

The outlook of companies tied to iconic drugs like Viagra presents a complex investment scenario . While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial profits , the patent expiration in key territories has introduced considerable uncertainty . Investors are now assessing the impact of rival medicatio